The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study

BACKGROUND: HER2 is a well-established prognostic and predictive factor in invasive breast cancer. The role of HER2 in ductal breast carcinoma in situ (DCIS) is debated and recent data have suggested that HER2 is mainly related to in situ recurrences. Our aim was to study HER2 as a prognostic factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgquist, Signe, Zhou, Wenjing, Jirström, Karin, Amini, Rose-Marie, Sollie, Thomas, Sørlie, Therese, Blomqvist, Carl, Butt, Salma, Wärnberg, Fredrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464713/
https://www.ncbi.nlm.nih.gov/pubmed/26062614
http://dx.doi.org/10.1186/s12885-015-1479-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464713/
https://www.ncbi.nlm.nih.gov/pubmed/26062614
http://dx.doi.org/10.1186/s12885-015-1479-3

Ejemplares similares